A phage display selected Fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes
- 1 November 2001
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (21) , 1601-1608
- https://doi.org/10.1038/sj.gt.3301570
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 38 references indexed in Scilit:
- Genetic re-targeting of T lymphocyte specifityGene Therapy, 1998
- A retroviral vector system ‘STITCH’ in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytesGene Therapy, 1998
- Correctly Folded T-cell Receptor Fragments in the Periplasm of Escherichia coliJournal of Molecular Biology, 1994
- Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2JNCI Journal of the National Cancer Institute, 1994
- Peptides Naturally Presented by MHC Class I MoleculesAnnual Review of Immunology, 1993
- Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell ClonesScience, 1992
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformationNature, 1991
- T-cell antigen receptor genes and T-cell recognitionNature, 1988
- RAPID EXPANSION OF ALLOSPECIFIC CYTOTOXIC T CELL CLONES USING NONSPECIFIC FEEDER CELL LINES WITHOUT FURTHER ADDITION OF EXOGENOUS IL2Transplantation, 1984